KIAT Bio Industry Open Ecosystem Promotion Program

Bio Industry Open Ecosystem Promotion Program funds Korean bio companies and consortia that are building shared industry infrastructure rather than product-specific R&D alone. KIAT runs it for MOTIE under the wider K-Bio strategy, and the programme centers on pilot GMP suites, translational service platforms, and open analytical facilities. The current 2026 round shows the route being used for infrastructure build-out with a focus on common-use bio manufacturing and testing capacity. The instrument is a grant on a multiple-per-year cycle, with Korean registration and operations required and consortium participation built into the design. Eligibility allows for-profit applicants and also permits universities, research organisations, and non-profits as partners, while individuals are excluded. The technical band runs from TRL 5 to 8, and the second-round integrated call opened on 15 May 2026 with an 8 June deadline. KIAT uses the programme for projects that can attract downstream users after build-out, so the fit is strongest when the applicant already has a site, a service plan, and a pathway to shared utilisation. The two-to-three-year horizon rewards teams that can show both construction discipline and a real user base for the facility. Applicants do best when they can turn an infrastructure proposal into a concrete platform that other companies will actually use.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.